Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
QMRO Home
Barts Cancer Institute
Centre for Tumour Biology
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
QMRO Home
Barts Cancer Institute
Centre for Tumour Biology
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
View/
Open
Published version (1.905Mb)
Volume
11
DOI
10.1038/s41467-020-18636-w
Journal
NATURE COMMUNICATIONS
Issue
1
ISSN
2041-1723
Metadata
Show full item record
Authors
Kocher, HM; Basu, B; Froeling, FEM; Sarker, D; Slater, S; Carlin, D; deSouza, NM; De Paepe, KN; Goulart, MR; Hughes, C
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67514
Collections
Centre for Tumour Biology
[374]
Licence information
Creative Commons Attribution 4.0 International License
Copyright statements
© The Author(s) 2020
Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International License